GATA1 mutation and trisomy 21 are required only in haematopoietic cells for development of transient myeloproliferative disorder
Open Access
- 1 February 2005
- journal article
- case report
- Published by Wiley in British Journal of Haematology
- Vol. 128 (4), 548-551
- https://doi.org/10.1111/j.1365-2141.2004.05342.x
Abstract
Trisomy 21 [Down's syndrome (DS)] and mutations in transcription factor GATA1 predispose neonates to a transient myeloproliferative disorder (TMD) and/or acute megakaryocytic leukaemia (AMKL). The role of trisomy 21 in their pathogenesis is unclear. We previously reported two rare neonates without DS who had TMD, one of whom progressed to AMKL. Trisomy 21 was detected only in blood cells at presentation with TMD/AMKL and disappeared with disease resolution. We now show that the blood cells at presentation of TMD harboured GATA1 genomic DNA mutations, suggesting a requirement for trisomy 21 in haematopoietic cells, rather than other cell types, for development of TMD/AMKL.Keywords
This publication has 12 references indexed in Scilit:
- Prenatal origin of GATA1 mutations may be an initiating step in the development of megakaryocytic leukemia in Down syndromeBlood, 2004
- Natural history of GATA1 mutations in Down syndromeBlood, 2004
- Recent insights into the mechanisms of myeloid leukemogenesis in Down syndromeBlood, 2004
- Fetal origin of the GATA1 mutation in identical twins with transient myeloproliferative disorder and acute megakaryoblastic leukemia accompanying Down syndromeBlood, 2004
- Frequent mutations in the GATA-1 gene in the transient myeloproliferative disorder of Down syndromeBlood, 2003
- Acquired mutations in GATA1 in neonates with Down's syndrome with transient myeloid disorderThe Lancet, 2003
- Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21Blood, 2003
- Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndromeNature Genetics, 2002
- Chromosome translocations and covert leukemic clones are generated during normal fetal developmentProceedings of the National Academy of Sciences of the United States of America, 2002
- Trisomy 21 associated transient neonatal myeloproliferation in the absence of Down's syndromeArchives of Disease in Childhood: Fetal & Neonatal, 1998